Smith Brendan

Related Filers (2)

Other (1)

144
Wednesday, 5/10/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (10)

4
Wednesday, 2/22/2023
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/18/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/12/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Monday, 10/18/2021
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
3
Friday, 10/15/2021
CRISPR Therapeutics AG: Initial statement of beneficial ownership of securities
4
Tuesday, 9/14/2021
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/20/2021
Translate Bio, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 4/20/2021
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
Show More